Dr. Jelena Marinković is a Senior Research Associate at the Laboratory of Physical Chemistry, "Vinča" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade. Her research is interdisciplinary, operating at the intersection of oral microbiology, natural products, and nano-formulations to develop novel alternatives to commercial antimicrobial agents:
Oral Microbiology & Natural Products: Building on her doctoral research, she evaluates the in vitro and ex vivo antibacterial and antibiofilm efficacy of essential oils and their active components.
Nanomaterials & Translational Applications: She applies advanced biological models to assess the antimicrobial potential of novel engineered nanomaterials, targeting applications such as root canal irrigants for endodontic infections and oral antiseptics for daily oral care.
Combating Multidrug-Resistant (MDR) Pathogens: Since 2024, her research has expanded to address critical global challenges in antimicrobial resistance, focusing on combating MDR strains belonging to the high-priority ESKAPE group.
Interdisciplinary Collaboration: She regularly contributes to material design and characterization, bridging experimental microbiology with applied materials science.
Dr. Marinković has a strong commitment to mentoring early-career researchers and contributing to academic peer evaluation.
Dr. Jelena Marinković is a Senior Research Associate at the Laboratory of Physical Chemistry, "Vinča" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade. Her research is interdisciplinary, operating at the intersection of oral microbiology, natural products, and nano-formulations to develop novel alternatives to commercial antimicrobial agents:
Oral Microbiology & Natural Products: Building on her doctoral research, she evaluates the in vitro and ex vivo antibacterial and antibiofilm efficacy of essential oils and their active components.
Nanomaterials & Translational Applications: She applies advanced biological models to assess the antimicrobial potential of novel engineered nanomaterials, targeting applications such as root canal irrigants for endodontic infections and oral antiseptics for daily oral care.
Combating Multidrug-Resistant (MDR) Pathogens: Since 2024, her research has expanded to address critical global challenges in antimicrobial resistance, focusing on combating MDR strains belonging to the high-priority ESKAPE group.
Interdisciplinary Collaboration: She regularly contributes to material design and characterization, bridging experimental microbiology with applied materials science.
Dr. Marinković has a strong commitment to mentoring early-career researchers and contributing to academic peer evaluation.